3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
von Hippel-Lindau Disease
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Neoplasms
1
Kidney Neoplasms
1
Hodgkin Disease
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Medullary
1
Breast Neoplasms
1
Adenocarcinoma, Follicular
1
Interventions
Cytarabine
21
fludarabine phosphate
8
Busulfan
8
Daunorubicin
7
Peripheral Blood Stem Cell Transplantation
6
Mitoxantrone
6
Idarubicin
6
Methotrexate
5
Gemtuzumab
5
Filgrastim
5
Etoposide
5
Clofarabine
5
tipifarnib
4
Whole-Body Irradiation
4
Vorinostat
4
Tacrolimus
4
Cyclosporine
4
Cyclophosphamide
4
Antilymphocyte Serum
4
sargramostim
3
alvocidib
3
Observation
3
Mycophenolic Acid
3
Flow Cytometry
3
Decitabine
3
Cytogenetic Analysis
3
Azacitidine
3
aldesleukin
2
Pravastatin
2
In Situ Hybridization, Fluorescence
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Megakaryoblastic, Acute
×
tanespimycin
×
Clear all
No trials found.